Clincosm LogoSign in Get a demo

Macular Degeneration

Showing NaN - NaN of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)

Recruiting
  • Geographic Atrophy
  • Macular Degeneration
  • Phoenix, Arizona
  • +3 more
Mar 31, 2023

Macular Degeneration, Geographic Atrophy Trial in Worldwide (IONIS-FB-LRx, Placebo)

Recruiting
  • Macular Degeneration
  • Geographic Atrophy
  • Phoenix, Arizona
  • +83 more
Aug 19, 2022

Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

Terminated
  • Dry Age-related Macular Degeneration
  • +4 more
  • Phoenix, Arizona
  • +28 more
Mar 22, 2022

Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration Trial in United States (GEM103, sham + SoC)

Completed
  • Neovascular Age-related Macular Degeneration
  • +3 more
  • GEM103
  • sham + SoC
  • Phoenix, Arizona
  • +22 more
Mar 22, 2022

Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

Completed
  • Geographic Atrophy
  • Macular Degeneration
  • Phoenix, Arizona
  • +77 more
Mar 17, 2022

Macular Degeneration Trial in Worldwide (Ranibizumab)

Completed
  • Macular Degeneration
  • Ranibizumab
  • Gilbert, Arizona
  • +101 more
Mar 11, 2022

Macular Degeneration Trial in United States (Ranibizumab)

Completed
Has Results
  • Macular Degeneration
  • Mesa, Arizona
  • +49 more
Apr 12, 2021

Natural Progression of Dry Age-related Macular Degeneration

Recruiting
  • Dry Age-related Macular Degeneration
  • +5 more
    • Phoenix, Arizona
    • +65 more
    Feb 22, 2021

    Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

    Completed
    • Dry Age-related Macular Degeneration
    • +4 more
    • GEM103
    • Phoenix, Arizona
    • +11 more
    Feb 9, 2021

    Age-Related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration Trial in Phoenix, Abilene, Arecibo

    Completed
    Has Results
    • Age-Related Macular Degeneration
    • +5 more
    • brolucuzumab 6 mg IVT
    • Phoenix, Arizona
    • +2 more
    Dec 9, 2020

    Macular Degeneration Trial in United States (Abicipar pegol)

    Completed
    Has Results
    • Macular Degeneration
    • Abicipar pegol
    • Phoenix, Arizona
    • +36 more
    Jul 17, 2020

    Macular Degeneration Trial in Worldwide (Abicipar Pegol, Ranibizumab, Sham Procedure)

    Completed
    Has Results
    • Macular Degeneration
    • Abicipar Pegol
    • +2 more
    • Birmingham, Alabama
    • +186 more
    Jul 17, 2020

    Macular Degeneration Trial in Worldwide (Abicipar Pegol, Ranibizumab, Sham Procedure)

    Completed
    Has Results
    • Macular Degeneration
    • Abicipar Pegol
    • +2 more
    • Phoenix, Arizona
    • +150 more
    Jul 16, 2020

    Geographic Atrophy, Macular Degeneration Trial in Worldwide (400 µg Brimonidine Implant, Sham)

    Terminated
    Has Results
    • Geographic Atrophy
    • Macular Degeneration
    • 400 µg Brimonidine Implant
    • Sham
    • Phoenix, Arizona
    • +40 more
    Mar 29, 2019

    Macular Degeneration Trial in Worldwide (pazopanib eye drops, , ranibizumab intravitreal injection)

    Completed
    Has Results
    • Macular Degeneration
    • pazopanib eye drops
    • +2 more
    • Peoria, Arizona
    • +76 more
    Dec 7, 2017

    Eye Diseases, Macular Degeneration, Retinal Diseases Trial in United States (OPT-302, Lucentis™)

    Completed
    • Eye Diseases
    • +4 more
    • Phoenix, Arizona
    • +13 more
    Nov 2, 2017

    Macular Degeneration Trial in France, Germany, United States (pazopanib eye drops)

    Terminated
    Has Results
    • Macular Degeneration
    • pazopanib eye drops
    • Phoenix, Arizona
    • +14 more
    Aug 23, 2017

    Macular Degeneration Trial in Phoenix (abicipar pegol, ranibizumab, sham procedure)

    Completed
    Has Results
    • Macular Degeneration
    • abicipar pegol
    • +2 more
    • Phoenix, Arizona
      (unnamed)
    Apr 15, 2016

    Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)

    Completed
    Has Results
    • Age-Related Maculopathy
    • +4 more
    • RN6G
    • Placebo
    • Phoenix, Arizona
    • +19 more
    Mar 20, 2015

    Macular Degeneration Trial in Canada, United States (bevasiranib, ranibizumab)

    Terminated
    Has Results
    • Macular Degeneration
    • Phoenix, Arizona
    • +59 more
    Sep 29, 2014

    Macular Degeneration Trial in United States (VEGF Trap Eye)

    Completed
    Has Results
    • Macular Degeneration
    • VEGF Trap Eye
    • Peoria, Arizona
    • +32 more
    Jun 10, 2013

    Macular Degeneration Trial in Canada, United States (ranibizumab, aflibercept injection (VEGF Trap-Eye, BAY86-5321))

    Completed
    Has Results
    • Macular Degeneration
    • ranibizumab
    • aflibercept injection (VEGF Trap-Eye, BAY86-5321)
    • Birmingham, Alabama
    • +187 more
    Dec 20, 2012

    Macular Degeneration Trial in United States (aflibercept injection (VEGF Trap-Eye, BAY86-5321))

    Completed
    Has Results
    • Macular Degeneration
    • aflibercept injection (VEGF Trap-Eye, BAY86-5321)
    • Phoenix, Arizona
    • +17 more
    Jan 27, 2012

    Macular Degeneration Trial in Worldwide (Epi-Rad90™ Ophthalmic System, ranibizumab)

    Unknown status
    • Macular Degeneration
    • Phoenix, Arizona
    • +31 more
    Jul 26, 2011

    Choroidal Neovascularization, Macular Degeneration Trial in Canada, United States (verteporfin, ranibizumab, dexamethasone)

    Completed
    Has Results
    • Choroidal Neovascularization
    • Macular Degeneration
    • Mobile, Alabama
    • +25 more
    May 31, 2011